Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride and dutasteride are equally effective and safe for treating BPH.

Oral finasteride seems more effective for hair loss in postmenopausal women, but more research is needed.

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

Taking medication for hair loss might cause sexual problems.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.

Older men with late-onset lupus have a higher mortality rate than women.

Young adults who had liver disease as children often experience significant health problems and frequently need transplants.

The severity of female pattern hair loss is linked to how long someone has had it, not to levels of certain nutrients or hormones.

Older age, being male, and Asian ethnicity led to worse COVID-19 outcomes, with many experiencing long-term symptoms.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

Trichoepitheliomas can be hard to distinguish from other skin conditions and often start in teenage years.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Stabilization of fibrosing alopecia may not mean effective disease control.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Spironolactone does not increase the risk of breast cancer recurrence.